Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.97% |
| 3 | Financials | 6.13% |
| 4 | Consumer Discretionary | 5.62% |
| 5 | Industrials | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
4726
Bicycle Therapeutics
BCYC
$278M
| $358K | ﹤0.01% |
16,836
-151,887
| -90% | -$3.81M |
|
4727
PUT
Charter Communications
CHTR
$18.8B
| $358K | ﹤0.01% |
1,000
-109,300
| -99% | -$40.8M |
|
4728
Ecopetrol
EC
$35.8B
| $357K | ﹤0.01% |
33,838
-2,347,849
| -99% | -$25.5M |
|
4729
OFS Capital
OFS
$50.8M
| $357K | ﹤0.01% |
34,682
+19,453
| +128% | +$196K |
|
4730
Citius Pharmaceuticals
CTXR
$17.6M
| $356K | ﹤0.01% |
12,179
-9,866
| -45% | -$284K |
|
|
OCFT
4731
DELISTED
OneConnect Financial Technology
OCFT
| $356K | ﹤0.01% |
67,006
+13,403
| +25% | +$90.3K |
|
4732
Southwest Gas
SWX
$6.69B
| $356K | ﹤0.01% |
5,700
-137,442
| -96% | -$8.76M |
|
4733
Rush Enterprises Class B
RUSHB
$6.05B
| $355K | ﹤0.01% |
8,903
-2,757
| -24% | -$107K |
|
4734
Aligos Therapeutics
ALGS
$34.1M
| $353K | ﹤0.01% |
16,135
+1,282
| +9% | +$49K |
|
4735
BrightView Holdings
BV
$1.02B
| $352K | ﹤0.01% |
62,661
-651,136
| -91% | -$4.39M |
|
4736
Crawford & Co Class A
CRD.A
$625M
| $351K | ﹤0.01% |
+41,939
| New | +$273K |
|
4737
CALL
Hewlett Packard
HPE
$69.4B
| $350K | ﹤0.01% |
22,000
| – | – |
|
4738
CALL
Live Nation Entertainment
LYV
$42.3B
| $350K | ﹤0.01% |
5,000
-47,700
| -91% | -$3.5M |
|
|
GRSD
4739
Grandstand Limited Ordinary Shares
GRSD
$66.8M
| $349K | ﹤0.01% |
35,196
+21,148
| +151% | +$203K |
|
4740
Latham Group
SWIM
$849M
| $349K | ﹤0.01% |
122,108
+47,538
| +64% | +$167K |
|
4741
Bogota Financial
BSBK
$111M
| $348K | ﹤0.01% |
34,333
-3,352
| -9% | -$37.5K |
|
4742
Novavax
NVAX
$1.27B
| $348K | ﹤0.01% |
50,257
-1,500,405
| -97% | -$13.8M |
|
4743
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.05B
| $348K | ﹤0.01% |
+19,495
| New | +$368K |
|
|
NXGN
4744
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $348K | ﹤0.01% |
+20,000
| New | +$360K |
|
4745
PUT
Affirm
AFRM
$25.6B
| $346K | ﹤0.01% |
+30,700
| New | +$387K |
|
|
RPT
4746
Rithm Property Trust
RPT
$94.2M
| $346K | ﹤0.01% |
8,773
-5,491
| -38% | -$261K |
|
4747
Aquestive Therapeutics
AQST
$492M
| $345K | ﹤0.01% |
302,848
+256,568
| +554% | +$222K |
|
4748
Sunstone Hotel Investors
SHO
$2.1B
| $345K | ﹤0.01% |
34,890
-874
| -2% | -$8.87K |
|
4749
Regal Rexnord
RRX
$11.9B
| $342K | ﹤0.01% |
2,431
-28,234
| -92% | -$4.09M |
|
4750
Bolt Biotherapeutics
BOLT
$7.44M
| $341K | ﹤0.01% |
12,271
+101
| +0.8% | +$2.96K |
|
Similar funds
Millennium Management's Q1 2023 Portfolio in Review
As of Q1 2023, Millennium Management held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Millennium Management withdrew a net $18.1B in Q1 2023, closing 1,209 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in Warner Bros worth $96.9M.
- Millennium Management's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Millennium Management added most to Linde in Q1 2023, an estimated $374M increase.
- Millennium Management's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Millennium Management fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Millennium Management's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Millennium Management opened 987 new positions and closed 1,209 in Q1 2023.
- Millennium Management's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.